Intensive management of obesity in people with Prader-Willi syndrome.

Brendan J Nolan Joseph Proietto Priya Sumithran

Published in: Endocrine (2022)

VLED and pharmacotherapy can achieve substantial weight loss in some individuals with PWS though non-adherence results in substantial weight regain. Adverse effects were ascribed to phentermine and topiramate, whereas liraglutide was well-tolerated in this population.

Keyphrases

weight loss
gastric bypass
growth hormone
bariatric surgery
roux en y gastric bypass
glycemic control
weight gain
case report
smoking cessation
obese patients
type diabetes
insulin resistance
metabolic syndrome
adipose tissue
high fat diet induced
body weight